A Study to Compare Urinary Exosomes in Healthy Kidney Donors and Renal Transplant Recipients

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-008733
    Sponsor Protocol Number: 16-008733

About this study

The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal transplant. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Healthy potential kidney donors
  • Kidney transplant recipient who have both a 24 hour urine and kidney transplant biopsy performed for standard of care purposes.

Exclusion Criteria:

  • Patients < age 18
  • Pregnant females

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Carrie Schinstock, M.D.

Contact us for the latest status

Contact information:

Shawna Cooper

(507)266-6953

Cooper.Shawna@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20318769

Mayo Clinic Footer